XTX Topco Ltd bought a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWI – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 54,211 shares of the company’s stock, valued at approximately $2,117,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in BBWI. Dimensional Fund Advisors LP increased its stake in shares of Bath & Body Works by 17.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,220,472 shares of the company’s stock valued at $52,675,000 after acquiring an additional 177,373 shares during the period. Envestnet Portfolio Solutions Inc. acquired a new position in shares of Bath & Body Works during the 4th quarter valued at $228,000. Vanguard Personalized Indexing Management LLC raised its stake in shares of Bath & Body Works by 5.3% in the 4th quarter. Vanguard Personalized Indexing Management LLC now owns 12,481 shares of the company’s stock worth $539,000 after buying an additional 632 shares in the last quarter. Panagora Asset Management Inc. acquired a new stake in shares of Bath & Body Works in the fourth quarter valued at $853,000. Finally, Great Lakes Advisors LLC bought a new position in Bath & Body Works during the fourth quarter valued at about $250,000. 95.14% of the stock is currently owned by institutional investors.
Bath & Body Works Price Performance
Shares of BBWI stock opened at $29.92 on Friday. Bath & Body Works, Inc. has a fifty-two week low of $26.20 and a fifty-two week high of $52.99. The stock’s 50-day moving average is $32.89 and its two-hundred day moving average is $40.98. The firm has a market cap of $6.68 billion, a P/E ratio of 7.71, a PEG ratio of 0.86 and a beta of 1.77.
Bath & Body Works Announces Dividend
Wall Street Analysts Forecast Growth
BBWI has been the topic of several research reports. Raymond James dropped their price target on shares of Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating on the stock in a research report on Thursday, August 29th. Robert W. Baird dropped their target price on shares of Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating on the stock in a report on Thursday, August 29th. Evercore ISI reduced their target price on shares of Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating for the company in a report on Wednesday, August 28th. Piper Sandler dropped their price target on Bath & Body Works from $47.00 to $39.00 and set a “neutral” rating on the stock in a report on Thursday, July 11th. Finally, Bank of America decreased their target price on Bath & Body Works from $54.00 to $45.00 and set a “buy” rating on the stock in a report on Thursday, August 29th. Eight equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $43.00.
Get Our Latest Stock Analysis on Bath & Body Works
Bath & Body Works Company Profile
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
Recommended Stories
- Five stocks we like better than Bath & Body Works
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- 5 discounted opportunities for dividend growth investors
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- Technology Stocks Explained: Here’s What to Know About Tech
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.